National Heart and Lung Institute, Imperial College London, London, UK
Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
BMJ Open Respir Res. 2020 Nov;7(1). doi: 10.1136/bmjresp-2020-000737.
Singing for lung health (SLH) is a popular arts-in-health activity for people with long-term respiratory conditions. Participants report biopsychosocial benefits, however, research on impact is limited. The 'SLH: Improving Experiences of Lung Disease trial', a randomised controlled, single (assessor) blind, trial of 12 weeks SLH versus usual care for people with chronic obstructive pulmonary disease (COPD) (n=120) was setup to help to address this. The first group (n=18, nine singing and nine controls) started face-to-face (five sessions) before changing to online delivery (seven sessions) due to COVID-19-related physical distancing measures. As such, the experience of this group is here reported as a pilot study to inform further research in this area.
We conducted semistructured interviews and thematic analysis regarding barriers, facilitators and key considerations for transitioning from face-to-face to online delivery. Pilot quantitative outcomes include attendance, premeasures and postmeasures of quality of life and disease impact (Short Form 36 Health Survey, COPD Assessment Test score), breathlessness (Medical Research Council breathlessness scale, Dyspnoea-12), depression (Patient Health Questionnaire-9, PHQ-9), anxiety (Generalised Anxiety Disorder-7), balance confidence (Activity specific Balance Confidence, ABC scale) and physical activity (clinical visit PROactive physical activity in COPD tool, combining subjective rating and actigraphy).
Attendance was 69% overall, (90% of the face-to-face sessions, 53% online sessions). Analysis of semistructured interviews identified three themes regarding participation in SLH delivered face to face and online, these where (1) perceived benefits; (2) digital barriers (online) and (3) digital facilitators (online). Findings were summarised into key considerations for optimising transitioning singing groups from face-to-face to online delivery. Pilot quantitative data suggested possible improvements in depression (treatment effect -4.78 PHQ-9 points, p<0.05, MCID 5) and balance confidence (treatment effect +17.21 ABC scale points, p=0.04, MCID 14.2).
This study identifies key considerations regarding the adaptation of SLH from face-to-face to online delivery. Pilot data suggest online group singing for people with COPD may deliver benefits related to reducing depression and improved balance confidence.
歌唱疗法(SLH)是一种针对慢性呼吸道疾病患者的流行的艺术治疗健康活动。参与者报告了生物心理社会收益,但关于其影响的研究有限。“SLH:改善肺部疾病体验试验”是一项为期 12 周的随机对照、单盲(评估者)试验,比较了慢性阻塞性肺疾病(COPD)患者的歌唱疗法(SLH)与常规护理(n=120),旨在帮助解决这个问题。第一组(n=18,9 名歌唱者和 9 名对照者)先进行面对面(5 次)治疗,然后由于 COVID-19 相关的物理距离措施改为在线治疗(7 次)。因此,本研究报告了这一组的经验,作为该领域进一步研究的试点研究。
我们进行了半结构化访谈和主题分析,以了解从面对面到在线治疗的过渡的障碍、促进因素和关键考虑因素。试点的定量结果包括出勤率、生活质量和疾病影响(36 项简短健康调查,COPD 评估测试评分)、呼吸困难(呼吸困难量表,呼吸困难 12 项)、抑郁(患者健康问卷 9 项,PHQ-9)、焦虑(广泛性焦虑症 7 项)、平衡信心(活动特异性平衡信心量表,ABC 量表)和体力活动(临床就诊 PROactive COPD 体力活动工具,结合主观评分和活动记录仪)的预测量和后测量。
总体出勤率为 69%(面对面课程的 90%,在线课程的 53%)。半结构化访谈分析确定了三个主题,涉及面对面和在线进行 SLH 治疗的参与情况,分别是:(1)感知收益;(2)数字障碍(在线);(3)数字促进因素(在线)。研究结果总结为优化从面对面到在线治疗过渡的歌唱小组的关键考虑因素。试点定量数据表明,在抑郁(治疗效果-4.78 个 PHQ-9 点,p<0.05,MCID 5)和平衡信心(治疗效果+17.21 ABC 量表点,p=0.04,MCID 14.2)方面可能有所改善。
本研究确定了从面对面到在线治疗过渡的 SLH 适应的关键考虑因素。试点数据表明,对于 COPD 患者,在线团体歌唱可能会带来降低抑郁和改善平衡信心的益处。